|
![]()
| Erin Kirwin Person1 #686720 Erin Kirwin (she/her) is a Health Economist at the Institute of Health Economics (IHE) in Alberta, Canada. She holds a Bachelor of Arts (Honours) in Economics and International Development Studies from McGill University and a Master of Arts in Economics from the University of Alberta. Prior to joining the IHE, Erin was the Manager of Advanced Analytics at Alberta Health. Erin is a PhD candidate at the University of Manchester. | 
- Erin has expertise in the use of routinely collected administrative data to inform public policy, with over ten years of experience working directly with administrative data. She has led cost-effectiveness analyses to support decision-making for immunization programs such as COVID-19, human papillomavirus, and herpes zoster vaccine. Her peer-reviewed work includes cost of illness analyses, economic evaluations, as well as mathematical modelling of mitigation strategies for pandemic influenza and COVID-19. Her PhD research focuses on theoretic and applied methods for the economic evaluation of interventions with very broad health system impacts.
|
+Citaten (2) - CitatenVoeg citaat toeList by: CiterankMapLink[2] Vaccine rollout strategies: The case for vaccinating essential workers early
Citerend uit: Nicola Mulberry, Paul Tupper, Erin Kirwin, Christopher McCabe, Caroline Colijn
Publication date: 13 October 2021
Publication info: PLOS Glob Public Health 1(10): e0000020
Geciteerd door: David Price 4:52 PM 15 December 2023 GMT
Citerank: (11) 679761Caroline ColijnDr. Caroline Colijn works at the interface of mathematics, evolution, infection and public health, and leads the MAGPIE research group. She joined SFU's Mathematics Department in 2018 as a Canada 150 Research Chair in Mathematics for Infection, Evolution and Public Health. She has broad interests in applications of mathematics to questions in evolution and public health, and was a founding member of Imperial College London's Centre for the Mathematics of Precision Healthcare.10019D3ABAB, 679770Christopher McCabeDr. Christopher McCabe is the CEO and Executive Director of the Institute of Health Economics (IHE).10019D3ABAB, 679862Paul TupperProfessor in the Department of Mathematics at Simon Fraser University.10019D3ABAB, 685420Hospitals16289D5D4, 701020CANMOD – PublicationsPublications by CANMOD Members144B5ACA0, 704041Vaccination859FDEF6, 704045Covid-19859FDEF6, 708794Health economics859FDEF6, 714608Charting a FutureCharting a Future for Emerging Infectious Disease Modelling in Canada – April 2023 [1] 2794CAE1, 715454Workforce impact859FDEF6, 715952Long covid859FDEF6 URL:
DOI: https://doi.org/10.1371/journal.pgph.0000020
| | Fragment- [PLOS Global Public Health, 13 October 2021]
In vaccination campaigns against COVID-19, many jurisdictions are using age-based rollout strategies, reflecting the much higher risk of severe outcomes of infection in older groups. In the wake of growing evidence that approved vaccines are effective at preventing not only adverse outcomes, but also infection, we show that such strategies are less effective than strategies that prioritize essential workers. This conclusion holds across numerous outcomes, including cases, hospitalizations, Long COVID (cases with symptoms lasting longer than 28 days), deaths and net monetary benefit. Our analysis holds in regions where the vaccine supply is limited, and rollout is prolonged for several months. In such a setting with a population of 5M, we estimate that vaccinating essential workers sooner prevents over 200,000 infections, over 600 deaths, and produces a net monetary benefit of over $500M. |
|
|